Contenido

Síguenos en…

Síguenos en Facebook. Pulsando en este enlace estarás saliendo de hvn.es   Síguenos en Twitter. Pulsando en este enlace estarás saliendo de hvn.es

Síguenos en YouTube. Pulsando en este enlace estarás saliendo de hvn.es   Feed de noticias

Publicaciones

Publicaciones (2014/2017)

  • J. Capdevila, JM. Trigo, J. Aller, JL. Manzano, S. Garcia-Adrian, C. Zafon, O. Reig, U. Bohn, T. Ramon Y Cajal, M. Duran, B. Gonzalez-Astorga, A. Lopez-Alfonso, J. Medina, I. Porras, JJ. Reina, N. Palacios, E. Grande, E. Cillan, I. Matos, JJ. Grau. Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC).. European journal of endocrinology. 2017 (doi:10.1530/EJE-17-0243 PMID:28687563)
  • N. Galiano-Castillo, M. Arroyo-Morales, M. Lozano-Lozano, C. Fernández-Lao, L. Martín-Martín, R. Del-Moral-Ávila, I. Cantarero-Villanueva. Effect of an Internet-based telehealth system on functional capacity and cognition in breast cancer survivors: a secondary analysis of a randomized controlled trial.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2017 (doi:10.1007/s00520-017-3782-9 PMID:28639097)
  • A. Carrato, A. Abad, B. Massuti, C. Grávalos, P. Escudero, F. Longo-Muñoz, JL. Manzano, A. Gómez, MJ. Safont, J. Gallego, B. García-Paredes, C. Pericay, R. Dueñas, F. Rivera, F. Losa, M. Valladares-Ayerbes, E. González, E. Aranda. First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-TTD).. European journal of cancer (Oxford, England : 1990). 2017 81: pp. 191 - 202 (doi:10.1016/j.ejca.2017.04.024 PMID:28633089)
  • AJ. Muñoz Martín, J. Adeva, J. Martínez-Galán, JJ. Reina, M. Hidalgo. Pancreatic ductal adenocarcinoma: metastatic disease.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2017 (doi:10.1007/s12094-017-1690-6 PMID:28623515)
  • C. Guillén-Ponce, J. Blázquez, I. González, E. de-Madaria, J. Montáns, A. Carrato. Diagnosis and staging of pancreatic ductal adenocarcinoma.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2017 (doi:10.1007/s12094-017-1681-7 PMID:28612200)
  • JM. Sepúlveda-Sánchez, MÁ. Vaz, C. Balañá, M. Gil-Gil, G. Reynés, Ó. Gallego, M. Martínez-García, E. Vicente, M. Quindós, R. Luque, A. Ramos, Y. Ruano, P. Pérez-Segura, M. Benavides, P. Sánchez-Gómez, A. Hernández-Laín. Phase II trial of dacomitinib, a pan-HER (human epidermal growth factor receptor) tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification.. Neuro-oncology. 2017 (doi:10.1093/neuonc/nox105 PMID:28575464)
  • MJ. Serrano, MJ. Alvarez-Cubero, D. De Miguel Pérez, A. Rodríguez-Martínez, L. Gonzalez-Herrera, I. Robles-Fernandez, JE. Hernandez, JLG. Puche, JA. Lorente. Significance of EGFR Expression in Circulating Tumor Cells.. Advances in experimental medicine and biology. 2017 994: pp. 285 - 296 (doi:10.1007/978-3-319-55947-6_16 PMID:28560681)
  • M. Mañós, J. Giralt, A. Rueda, J. Cabrera, J. Martinez-Trufero, J. Marruecos, A. Lopez-Pousa, JP. Rodrigo, B. Castelo, J. Martínez-Galán, F. Arias, M. Chaves, JJ. Herranz, V. Arrazubi, N. Baste, A. Castro, R. Mesía. Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1).. Oral oncology. 2017 (doi:10.1016/j.oraloncology.2017.04.004 PMID:28427761)
  • CI. Bayarri-Lara, D. de Miguel Pérez, A. Cueto Ladrón de Guevara, A. Rodriguez Fernández, JL. Puche, A. Sánchez-Palencia Ramos, J. Ruiz Zafra, CF. Giraldo Ospina, M. Delgado-Rodríguez, M. Expósito Ruiz, MJ. Moyano Rodriguez, JA. Lorente, MJ. Serrano. Association of circulating tumour cells with early relapse and 18F-fluorodeoxyglucose positron emission tomography uptake in resected non-small-cell lung cancers†.. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 2017 (doi:10.1093/ejcts/ezx049 PMID:28369376)
  • N. Mendoza, F. Molero, F. Criado, MJ. Cornellana, E. González. Sexual health after breast cancer: Recommendations from the Spanish Menopause Society, Federación Española de Sociedades de Sexología, Sociedad Española de Médicos de Atención Primaria and Sociedad Española de Oncología Médica.. Maturitas. 2017 (doi:10.1016/j.maturitas.2017.02.010 PMID:28268037)
  • JM. Cejalvo, E. Martínez de Dueñas, P. Galván, S. García-Recio, O. Burgués Gasión, L. Paré, S. Antolín, R. Martinello, I. Blancas, B. Adamo, Á. Guerrero-Zotano, M. Muñoz, P. Nucíforo, M. Vidal, RM. Pérez, JI. Chacón López-Muniz, R. Caballero, V. Peg, E. Carrasco, F. Rojo, CM. Perou, J. Cortés, V. Adamo, J. Albanell, RR. Gomis, A. Lluch, A. Prat. Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.. Cancer research. 2017 (doi:10.1158/0008-5472.CAN-16-2717 PMID:28249905)
  • A. Irigoyen, J. Gallego, C. Guillén Ponce, R. Vera, V. Iranzo, I. Ales, S. Arévalo, A. Pisa, M. Martín, A. Salud, E. Falcó, A. Sáenz, JL. Manzano Mozo, G. Pulido, J. Martínez Galán, R. Pazo-Cid, F. Rivera, T. García García, O. Serra, EM. Fernández Parra, A. Hurtado, MJ. Gómez Reina, LJ. López Gomez, E. Martínez Ortega, M. Benavides, E. Aranda. Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group.. European journal of cancer (Oxford, England : 1990). 2017 75: pp. 73 - 82 (doi:10.1016/j.ejca.2016.12.032 PMID:28222309)
  • C. Morata-Tarifa, M. Picon-Ruiz, C. Griñan-Lison, H. Boulaiz, M. Perán, MA. Garcia, JA. Marchal. Validation of suitable normalizers for miR expression patterns analysis covering tumour heterogeneity.. Scientific reports. 2017 7: pp. 39782 - 39782 (doi:10.1038/srep39782 PMID:28051134)
  • R. Mesía, JA. Garcia-Saenz, A. Lozano, M. Pastor, JJ. Grau, J. Martínez-Trufero, J. Lambeaz, J. Martínez-Galán, JR. Mel, B. González, S. Vázquez, M. Mañós, M. Taberna, B. Cirauqui, ED. Barco, E. Casado, J. Rubió-Casadevall, A. Rodríguez-Jaráiz, JJ. Cruz. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group . International journal of radiation oncology, biology, physics. 2017 97(3): pp. 473 - 480 (doi:10.1016/j.ijrobp.2016.11.016 PMID:28011050)
  • FF. Pérez, J. Lavernia, D. Aguiar-Bujanda, J. Miramón, J. Gumá, R. Álvarez, J. Gómez-Codina, FG. Arroyo, M. Llanos, M. Marin, J. Alfaro, C. Quero, M. Delgado, E. Nogales, F. Menarguez, N. Martinez, M. Torrente, A. Royuela, D. Abreu, M. Provencio. Primary Breast Lymphoma: Analysis of 55 Cases of the Spanish Lymphoma Oncology Group.. Clinical lymphoma, myeloma & leukemia. 2017 17(3): pp. 186 - 191. FI: 2.316 (Cuartil Q3). (doi:10.1016/j.clml.2016.09.004 PMID:27847267)
  • M. Martin Jimenez, A. Calvo Ferrandiz, J. Aparicio Urtasun, R. Garcia-Campelo, E. Gonzalez-Flores, M. Lazaro Quintela, M. Muñoz Mateu, CA. Rodriguez Sanchez, A. Santaballa Bertran, JM. Sepulveda Sanchez, R. Vera Garcia, JA. Virizuela Echaburu, MA. Segui Palmer. New clinical trials regulation in Spain: analysis of royal decree 1090/2015.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2017 19(3): pp. 291 - 300. FI: 2.075 (Cuartil Q3). (doi:10.1007/s12094-016-1550-9 PMID:27718157)
  • R. García-Carbonero, R. Vera, F. Rivera, E. Parlorio, M. Pagés, E. González-Flores, C. Fernández-Martos, MÁ. Corral, R. Bouzas, F. Matute. SEOM/SERAM consensus statement on radiological diagnosis, response assessment and follow-up in colorectal cancer.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2017 19(2): pp. 135 - 148 (doi:10.1007/s12094-016-1518-9 PMID:27206566)
  • J. Capellades, P. Teixidor, G. Villalba, C. Hostalot, G. Plans, R. Armengol, S. Medrano, A. Estival, R. Luque, S. Gonzalez, M. Gil-Gil, S. Villa, J. Sepulveda, JJ. García-Mosquera, C. Balana. Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2016. FI: 2.075 (Cuartil Q3). (doi:10.1007/s12094-016-1598-6 PMID:28005261)
  • M. Hidalgo, R. Álvarez, J. Gallego, C. Guillén-Ponce, B. Laquente, T. Macarulla, A. Muñoz, M. Salgado, R. Vera, J. Adeva, I. Alés, S. Arévalo, J. Blázquez, A. Calsina, A. Carmona, E. de Madaria, R. Díaz, L. Díez, T. Fernández, BG. de Paredes, ME. Gallardo, I. González, O. Hernando, P. Jiménez, A. López, C. López, F. López-Ríos, E. Martín, J. Martínez, A. Martínez, J. Montans, R. Pazo, JC. Plaza, I. Peiró, JJ. Reina, A. Sanjuanbenito, R. Yaya, A. Carrato. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2016. FI: 2.075 (Cuartil Q3). (doi:10.1007/s12094-016-1594-x PMID:27995549)
  • E. González-Flores, F. Losa, C. Pericay, E. Polo, S. Roselló, MJ. Safont, R. Vera, J. Aparicio, MT. Cano, C. Fernández-Martos. SEOM Clinical Guideline of localized rectal cancer (2016).. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2016 18(12): pp. 1163 - 1171. FI: 2.075 (Cuartil Q3). (doi:10.1007/s12094-016-1591-0 PMID:27905053)
  • J. Alcaide, M. Delgado, M. Legerén, JM. Jurado, I. Blancas, T. Pereda, J. López, M. Garrido, MJ. Sánchez, JL. García, A. Rueda. Efficacy and safety of aflibercept in metastatic colorectal cancer pretreated with bevacizumab: A report of five cases.. Oncology letters. 2016 12(5): pp. 3127 - 3134. FI: 1.482 (Cuartil Q4). (doi:10.3892/ol.2016.5068 PMID:27899972)
  • R. Vera, E. Dotor, J. Feliu, E. González, B. Laquente, T. Macarulla, E. Martínez, J. Maurel, M. Salgado, JL. Manzano. SEOM Clinical Guideline for the treatment of pancreatic cancer (2016).. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2016 18(12): pp. 1172 - 1178. FI: 2.075 (Cuartil Q3). (doi:10.1007/s12094-016-1586-x PMID:27896637)
  • E. Del Barco Morillo, R. Mesía, JC. Adansa Klain, S. Vázquez Fernández, J. Martínez-Galán, M. Pastor Borgoñon, C. González-Rivas, J. Caballero Daroqui, A. Berrocal, J. Martínez-Trufero, R. Vera, JJ. Cruz-Hernández. Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study.. Oral oncology. 2016 62: pp. 54 - 59. FI: 4.286 (Cuartil Q1). (doi:10.1016/j.oraloncology.2016.09.009 PMID:27865372)
  • D. Molina, J. Pérez-Beteta, A. Martínez-González, JM. Sepúlveda, S. Peralta, MJ. Gil-Gil, G. Reynes, A. Herrero, R. De Las Peñas, R. Luque, J. Capellades, C. Balaña, VM. Pérez-García. Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients.. PloS one. 2016 11(8): pp. e0161484 - e0161484. FI: 3.057 (Cuartil Q1). (doi:10.1371/journal.pone.0161484 PMID:27557121)
  • C. Pérez-Ramírez, M. Cañadas-Garre, A. Alnatsha, E. Villar, JR. Delgado, MJ. Faus-Dáder, MÁ. Calleja-Hernández. PHARMACOGENETIC PREDICTORS OF TOXICITY TO PLATINUM BASED CHEMOTHERAPY IN NON-SMALL CELL LUNG CANCER PATIENTS.. Pharmacological research. 2016 111: pp. 877 - 884. FI: 4.816 (Cuartil Q1). (doi:10.1016/j.phrs.2016.08.002 PMID:27498158)
  • C. Fernández-López, J. Expósito-Hernández, JP. Arrebola-Moreno, MÁ. Calleja-Hernández, M. Expósito-Ruíz, R. Guerrero-Tejada, I. Linares, J. Cabeza-Barrera. Trends in phase III randomized controlled clinical trials on the treatment of advanced non-small-cell lung cancer.. Cancer medicine. 2016 5(9): pp. 2190 - 2197. FI: 2.915 (Cuartil Q3). (doi:10.1002/cam4.782 PMID:27449070)
  • E. López-Ruiz, G. Jiménez, MÁ. García, C. Antich, H. Boulaiz, JA. Marchal, M. Perán. Polymers, scaffolds and bioactive molecules with therapeutic properties in osteochondral pathologies: what's new?. Expert opinion on therapeutic patents. 2016 26(8): pp. 877 - 890. FI: 4.626 (Cuartil Q1). (doi:10.1080/13543776.2016.1203903 PMID:27337937)
  • N. Galiano-Castillo, I. Cantarero-Villanueva, C. Fernández-Lao, A. Ariza-García, L. Díaz-Rodríguez, R. Del-Moral-Ávila, M. Arroyo-Morales. Telehealth system: A randomized controlled trial evaluating the impact of an internet-based exercise intervention on quality of life, pain, muscle strength, and fatigue in breast cancer survivors.. Cancer. 2016 122(20): pp. 3166 - 3174. FI: 5.649 (Cuartil Q1). (doi:10.1002/cncr.30172 PMID:27332968)
  • MdelM. Alfaya Góngora, MJ. Bueno Pernias, C. Hueso Montoro, P. Guardia Mancilla, R. Montoya Juárez, MP. García Caro. Palliative care team visits. Qualitative study through participant observation.. Colombia medica (Cali, Colombia). 2016 47(1): pp. 38 - 44. FI: 0.873 (Cuartil Q3). ( PMID:27226663)
  • JP. Arrebola, M. Fernández-Rodríguez, F. Artacho-Cordón, C. Garde, F. Perez-Carrascosa, I. Linares, I. Tovar, B. González-Alzaga, J. Expósito, P. Torne, MF. Fernández, N. Olea. Associations of persistent organic pollutants in serum and adipose tissue with breast cancer prognostic markers.. The Science of the total environment. 2016 566-567: pp. 41 - 49. FI: 3.976 (Cuartil Q1). (doi:10.1016/j.scitotenv.2016.04.188 PMID:27213669)
  • J. González-Moreno, I. Losada-López, C. Gállego-Lezaun, M. García-Gasalla, C. Gómez Bellvert, N. Ortego Centeno. Serosal involvement in IgG4-related disease: report of two cases and review of the literature.. Rheumatology international. 2016 36(7): pp. 1033 - 1041. FI: 1.702 (Cuartil Q3). (doi:10.1007/s00296-016-3501-8 PMID:27207156)
  • I. Linares, J. Expósito, JP. Arrebola, J. Sánchez-Cantalejo, YL. Chang-Chan, E. Molina, R. Guerrero, MJ. Sánchez. 33P Prognostic factors associated with lung cancer survival. A population-based study in the South of Spain.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2016 11(4 Suppl): pp. S69 - S69. FI: 5.04 (Cuartil Q1). (doi:10.1016/S1556-0864(16)30147-2 PMID:27198389)
  • A. Madrid-Paredes, M. Cañadas-Garre, A. Sánchez-Pozo, AM. Segura-Pérez, CC. Santos, EV. Alcaide, LC. Portellano, MÁ. Calleja-Hernández. ABCB1 C3435T GENE POLYMORPHISM AS A POTENTIAL BIOMARKER OF CLINICAL OUTCOMES IN HER2-POSITIVE BREAST CANCER PATIENTS.. Pharmacological research. 2016 108: pp. 111 - 118. FI: 4.816 (Cuartil Q1). (doi:10.1016/j.phrs.2016.04.016 PMID:27137881)
  • I. Jiménez-Díaz, F. Artacho-Cordón, F. Vela-Soria, H. Belhassen, JP. Arrebola, MF. Fernández, R. Ghali, A. Hedhili, N. Olea. Urinary levels of bisphenol A, benzophenones and parabens in Tunisian women: A pilot study.. The Science of the total environment. 2016 562: pp. 81 - 88. FI: 3.976 (Cuartil Q1). (doi:10.1016/j.scitotenv.2016.03.203 PMID:27096629)
  • I. Duran, C. Hagen, JÁ. Arranz, M. Apellaniz-Ruiz, B. Pérez-Valderrama, N. Sala, N. Lainez, X. García-Del Muro, E. Noguerón, MÁ. Climent, P. Maroto, A. Font, J. García-Donas, E. Gallardo, P. López-Criado, A. González Del Alba, MI. Sáez, S. Vázquez, R. Luque, C. Rodríguez-Antona. SNPs associated with activity and toxicity of cabazitaxel in patients with advanced urothelial cell carcinoma.. Pharmacogenomics. 2016 17(5): pp. 463 - 471. FI: 2.71 (Cuartil Q2). (doi:10.2217/pgs.15.186 PMID:27020167)
  • C. Bayarri-Lara, FG. Ortega, A. Cueto Ladrón de Guevara, JL. Puche, J. Ruiz Zafra, D. de Miguel-Pérez, AS. Ramos, CF. Giraldo-Ospina, JA. Navajas Gómez, M. Delgado-Rodriguez, JA. Lorente, MJ. Serrano. Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection.. PloS one. 2016 11(2): pp. e0148659 - e0148659. FI: 3.057 (Cuartil Q1). (doi:10.1371/journal.pone.0148659 PMID:26913536)
  • C. Balana, R. De Las Penas, JM. Sepúlveda, MJ. Gil-Gil, R. Luque, O. Gallego, C. Carrato, C. Sanz, G. Reynes, A. Herrero, JL. Ramirez, P. Pérez-Segura, A. Berrocal, JM. Vieitez, A. Garcia, S. Vazquez-Estevez, S. Peralta, I. Fernandez, I. Henriquez, M. Martinez-Garcia, JJ. De la Cruz, J. Capellades, P. Giner, S. Villà. Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial.. Journal of neuro-oncology. 2016 127(3): pp. 569 - 579. FI: 2.754 (Cuartil Q2). (doi:10.1007/s11060-016-2065-5 PMID:26847813)
  • R. Mesía, S. Vázquez, JJ. Grau, JA. García-Sáenz, A. Lozano, C. García, J. Carles, A. Irigoyen, M. Mañós, B. García-Paredes, E. Del Barco, M. Taberna, Y. Escobar, JJ. Cruz. A Phase 2 Open Label, Single-arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients With Unresectable Squamous Cell Carcinoma of the Head and Neck.. International journal of radiation oncology, biology, physics. 2016 94(2): pp. 289 - 296. FI: 4.495 (Cuartil Q1). (doi:10.1016/j.ijrobp.2015.10.019 PMID:26675064)
  • B. Pérez-Valderrama, JA. Arranz Arija, A. Rodríguez Sánchez, A. Pinto Marín, P. Borrega García, DE. Castellano Gaunas, G. Rubio Romero, C. Maximiano Alonso, JC. Villa Guzmán, JL. Puertas Álvarez, I. Chirivella González, MJ. Méndez Vidal, MJ. Juan Fita, L. León-Mateos, M. Lázaro Quintela, R. García Domínguez, JM. Jurado García, E. Vélez de Mendizábal, JJ. Lambea Sorrosal, I. García Carbonero, A. González Del Alba, C. Suárez Rodríguez, P. Jiménez Gallego, JA. Meana García, RD. García Marrero, P. Gajate Borau, C. Santander Lobera, C. Molins Palau, M. López Brea, EM. Fernández Parra, O. Reig Torras, L. Basterretxea Badiola, S. Vázquez Estévez, JL. González Larriba. Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: The Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study.. Annals of oncology : official journal of the European Society for Medical Oncology. 2016 27(4): pp. 706 - 711. FI: 9.269 (Cuartil Q1). (doi:10.1093/annonc/mdv601 PMID:26658889)
  • MF. Fernández, JP. Arrebola, I. Jiménez-Díaz, JM. Sáenz, JM. Molina-Molina, O. Ballesteros, A. Kortenkamp, N. Olea. Bisphenol A and other phenols in human placenta from children with cryptorchidism or hypospadias.. Reproductive toxicology (Elmsford, N.Y.). 2016 59: pp. 89 - 95. FI: 2.85 (Cuartil Q2). (doi:10.1016/j.reprotox.2015.11.002 PMID:26602963)
  • C. Torres, A. Linares, MJ. Alejandre, RJ. Palomino-Morales, JR. Delgado, S. Perales. Interplay Between Gemcitabine and Erlotinib Over Pancreatic Adenocarcinoma Cells.. Pancreas. 2016 45(2): pp. 269 - 280. FI: 2.738 (Cuartil Q2 - Decil 4). (doi:10.1097/MPA.0000000000000452 PMID:26495790)
  • I. Linares, MI. Tovar, M. Zurita, R. Guerrero, M. Expósito, RD. Moral. Hypofractionated Breast Radiation: Shorter Scheme, Lower Toxicity.. Clinical breast cancer. 2016 16(4): pp. 262 - 268. FI: 3.082 (Cuartil Q2 - Decil 15). (doi:10.1016/j.clbc.2015.09.012 PMID:26454613)
  • I. Linares, E. Molina-Portillo, J. Expósito, JA. Baeyens, C. Suárez, MJ. Sánchez. Trends in lung cancer incidence by histologic subtype in the south of Spain, 1985-2012: a population-based study.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2016 18(5): pp. 489 - 496. FI: 2.075 (Cuartil Q3). (doi:10.1007/s12094-015-1392-x PMID:26329296)
  • AJ. Conde-Moreno, JL. Lopez-Guerra, VA. Macias, ML. Vázquez de la Torre, P. Samper Ots, S. San José-Maderuelo, J. Pastor Peidro, J. López-Torrecilla, J. Expósito-Hernández. Spanish Society of Radiation Oncology clinical guidelines for stereotactic body radiation therapy in lymph node oligometastases.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2016 18(4): pp. 342 - 351. FI: 2.075 (Cuartil Q3). (doi:10.1007/s12094-015-1383-y PMID:26329294)
  • I. Tovar Martín, R. Del Moral Ávila, M. Zurita Herrera, G. Arregui, JL. Osorio-Ceballos, E. Saura Rojas, Á. Horcajadas Almansa, JP. Arrebola, J. Pastor Rull, J. Expósito Hernández, E. López Ramírez. The role of radiosurgery in the management of glomus tumours.. Head & neck. 2016 38(S1): pp. E798 - 804. FI: 2.76 (Cuartil Q1 - Decil 1). (doi:10.1002/hed.24103 PMID:25914332)
  • MJ. Alvarez-Cubero, F. Vázquez-Alonso, I. Puche-Sanz, FG. Ortega, M. Martin-Prieto, JL. Garcia-Puche, M. Pascual-Geler, JA. Lorente, JM. Cozar-Olmo, MJ. Serrano-Fernández. Dormant Circulating Tumor Cells In Prostate Cancer: Biological, Clinical And Therapeutic Implications.. Current drug targets. 2016 1(1). FI: 3.029 (Cuartil Q2 - Decil 6). ( PMID:25751007)
  • E. Almagro, CS. González, E. Espinosa. Prognostic factors of early breast cancer.. Medicina clinica. 2016 146(4): pp. 167 - 171. FI: 1.267 (Cuartil Q2 - Decil 9). (doi:10.1016/j.medcli.2014.12.019 PMID:25726309)
  • J. Expósito, I. Linares, I. Castillo, M. Martínez, P. Vargas, I. Herruzo, JA. Medina, A. Palacios, E. Bayo, F. Peracaula, J. Jaén, JA. Sánchez, MJ. Ortiz. Evaluation of the utilization of external radiotherapy in the treatment of localized prostate cancer in Andalusia, Spain.. Radiation oncology (London, England). 2015 10(1): pp. 265 - 265. FI: 2.466 (Cuartil Q3). (doi:10.1186/s13014-015-0572-8 PMID:26715201)
  • MA. Gentil, C. Gonzalez-Corvillo, P. Castro, P. Ruiz-Esteban, C. Gracia-Guindo, T. Garcia-Alvarez, ML. Agüera, L. Ballesteros, A. Osuna, M. Alonso. Impact of Asystolic Donations in Kidney Transplant Activity From Cadaveric Donors in Andalusia.. Transplantation proceedings. 2015 47(9): pp. 2584 - 2586. FI: 0.867 (Cuartil Q4). (doi:10.1016/j.transproceed.2015.09.046 PMID:26680042)
  • MA. Gentil, P. Castro, L. Ballesteros, MC. Gracia-Guindo, M. Cabello, MA. Mazuecos, A. Rodriguez-Benot, C. Gonzalez-Corvillo, J. Borrego, AO. Ortega, M. Alonso. Survival of Kidney Allograft of Donors after Circulatory Death Is Similar to Donors after Brain Death: Experience in a Regional Program.. Transplantation proceedings. 2015 47(9): pp. 2572 - 2574. FI: 0.867 (Cuartil Q4). (doi:10.1016/j.transproceed.2015.09.045 PMID:26680038)
  • F. Navarro Freire, P. Navarro Sánchez, B. Mirón Pozo, MT. Delgado Ureña, JA. Jiménez Ríos, PA. García López, JI. Arcelus Martínez. Recurrence of liver metastases from colorectal cancer and repeat liver resection.. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 2015 107(12): pp. 732 - 739. FI: 1.455 (Cuartil Q4). (doi:10.17235/reed.2015.3843/2015 PMID:26671585)
  • MD. Cano-Garcia, R. Casares-Perez, M. Arrabal-Martin, S. Merino-Salas, MA. Arrabal-Polo. Use of Lidocaine 2% Gel Does Not Reduce Pain during Flexible Cystoscopy and Is Not Cost-Effective.. Urology journal. 2015 12(5): pp. 2362 - 2365. FI: 0.737 (Cuartil Q4). ( PMID:26571322)
  • G. Perazzoli, J. Prados, R. Ortiz, O. Caba, L. Cabeza, M. Berdasco, B. Gónzalez, C. Melguizo. Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression.. PloS one. 2015 10(10): pp. e0140131 - e0140131. FI: 3.057 (Cuartil Q1). (doi:10.1371/journal.pone.0140131 PMID:26447477)
  • C. Lepage, R. Capocaccia, M. Hackl, V. Lemmens, E. Molina, D. Pierannunzio, M. Sant, A. Trama, J. Faivre. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5.. European journal of cancer (Oxford, England : 1990). 2015 51(15): pp. 2169 - 2178. FI: 6.163 (Cuartil Q1). (doi:10.1016/j.ejca.2015.07.034 PMID:26421820)
  • C. Torres, A. Linares, MJ. Alejandre, RJ. Palomino-Morales, O. Caba, J. Prados, A. Aránega, JR. Delgado, A. Irigoyen, J. Martínez-Galán, FM. Ortuño, I. Rojas, S. Perales. Prognosis Relevance of Serum Cytokines in Pancreatic Cancer.. BioMed research international. 2015 2015: pp. 518284 - 518284. FI: 2.134 (Cuartil Q3 - Decil 9). (doi:10.1155/2015/518284 PMID:26346854)
  • F. Artacho-Cordón, M. Fernández-Rodríguez, C. Garde, E. Salamanca, LM. Iribarne-Durán, P. Torné, J. Expósito, L. Papay-Ramírez, MF. Fernández, N. Olea, JP. Arrebola. Serum and adipose tissue as matrices for assessment of exposure to persistent organic pollutants in breast cancer patients.. Environmental research. 2015 142: pp. 633 - 643. FI: 3.088 (Cuartil Q2 - Decil 2). (doi:10.1016/j.envres.2015.08.020 PMID:26318258)
  • M. Real, JM. Molina-Molina, J. Jimenez, HR. Diéguez, MF. Fernández, N. Olea. Assessment of hormone-like activities in Ginkgo biloba, Elettaria cardamomum and Plantago ovata extracts using in vitro receptor-specific bioassays.. Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment. 2015 32(9): pp. 1531 - 1541. FI: 1.878 (Cuartil Q3). (doi:10.1080/19440049.2015.1071922 PMID:26161806)
  • R. Vera, V. Alonso, J. Gállego, E. González, C. Guillén-Ponce, C. Pericay, F. Rivera, MJ. Safont, M. Valladares-Ayerbes. Current controversies in the management of metastatic colorectal cancer.. Cancer chemotherapy and pharmacology. 2015 76(4): pp. 659 - 677. FI: 2.824 (Cuartil Q2 - Decil 10). (doi:10.1007/s00280-015-2808-6 PMID:26113053)
  • CGP. GOMEZ-PEÑA, CLDF. DAVILA-FAJARDO, LJMG. MARTINEZ-GONZALEZ, PCS. CARMONA-SAEZ, MJSP. SOTO-PINO, JSR. SANCHEZ-RAMOS, EME. MORENO-ESCOBAR, IB. BLANCAS, JJF. FERNANDEZ, DF. FERNANDEZ, CCV. CORREA-VILCHES, JCB. CABEZA-BARRERA. Influence of the HER2 Ile655Val polymorphism on trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients: a meta-analysis. Pharmacogenetics and genomics. 2015 25(8): pp. 388 - 393. FI: 2.857 (Cuartil Q2). (doi:10.1097/FPC.0000000000000149 PMID:26049584)
  • P. Garcia-Alfonso, M. Chaves, A. Muñoz, A. Salud, M. García-Gonzalez, C. Grávalos, B. Massuti, E. González-Flores, B. Queralt, A. López-Ladrón, F. Losa, MJ. Gómez, A. Oltra, E. Aranda. Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study.. BMC cancer. 2015 15(1): pp. 327 - 327. FI: 3.265 (Cuartil Q2 - Decil 8). (doi:10.1186/s12885-015-1293-y PMID:25925749)
  • J. Orgaz-Molina, M. Cotugno, MS. Girón-Prieto, MA. Arrabal-Polo, JC. Ruiz-Carrascosa, A. Buendía-Eisman, S. Arias-Santiago. A study of internet searches for medical information in dermatology patients: The patient-physician relationship.. Actas dermo-sifiliograficas. 2015 106(6): pp. 493 - 499 (doi:10.1016/j.ad.2015.01.011 PMID:25805250)
  • JP. Arrebola, H. Belhassen, F. Artacho-Cordón, R. Ghali, H. Ghorbel, H. Boussen, FM. Perez-Carrascosa, J. Expósito, A. Hedhili, N. Olea. Risk of female breast cancer and serum concentrations of organochlorine pesticides and polychlorinated biphenyls: A case-control study in Tunisia.. The Science of the total environment. 2015 520: pp. 106 - 113. FI: 3.976 (Cuartil Q1 - Decil 4). (doi:10.1016/j.scitotenv.2015.03.045 PMID:25804877)
  • JM. Avecillas-Chasin, J. Saceda-Gutierrez, P. Alonso-Lera, R. Garcia-Pumarino, S. Issa, E. López, JA. Barcia. Scalp Metastases of Recurrent Meningiomas: Aggressive Behavior or Surgical Seeding?. World neurosurgery. 2015 84(1): pp. 121 - 131. FI: 2.685 (Cuartil Q2). (doi:10.1016/j.wneu.2015.02.041 PMID:25765926)
  • JP. Arrebola, MF. Fernández, P. Martin-Olmedo, JP. Bonde, JL. Martín-Rodriguez, J. Expósito, A. Rubio-Domínguez, N. Olea. Historical exposure to persistent organic pollutants and risk of incident hypertension.. Environmental research. 2015 138C: pp. 217 - 223. FI: 3.088 (Cuartil Q2 - Decil 2). (doi:10.1016/j.envres.2015.02.018 PMID:25725302)
  • L. Cabeza, R. Ortiz, JL. Arias, J. Prados, MA. Ruiz Martínez, JM. Entrena, R. Luque, C. Melguizo. Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles.. International journal of nanomedicine. 2015 10: pp. 1291 - 1306. FI: 4.32 (Cuartil Q1 - Decil 4). (doi:10.2147/IJN.S74378 PMID:25709449)
  • I. Calvente, MF. Fernández, R. Pérez-Lobato, C. Dávila-Arias, O. Ocón, R. Ramos, S. Ríos-Arrabal, J. Villalba-Moreno, N. Olea, MI. Núñez. Outdoor characterization of radio frequency electromagnetic fields in a Spanish birth cohort.. Environmental research. 2015 138: pp. 136 - 143. FI: 3.088 (Cuartil Q2). (doi:10.1016/j.envres.2014.12.013 PMID:25707018)
  • M. Real, JM. Molina-Molina, I. Jiménez-Díaz, JP. Arrebola, JM. Sáenz, MF. Fernández, N. Olea. Screening of hormone-like activities in bottled waters available in Southern Spain using receptor-specific bioassays.. Environment international. 2015 74: pp. 125 - 135. FI: 5.929 (Cuartil Q1). (doi:10.1016/j.envint.2014.10.006 PMID:25454229)
  • C. Torres, A. Linares, MJ. Alejandre, R. Palomino-Morales, M. Martin, JR. Delgado, J. Martinez, S. Perales. The Potential Role of the Glycoprotein Osteoactivin/Glycoprotein Nonmetastatic Melanoma Protein B in Pancreatic Cancer.. Pancreas. 2015 44(2): pp. 302 - 310. FI: 2.738 (Cuartil Q2). (doi:10.1097/MPA.0000000000000250 PMID:25426614)
  • R. Pérez-Lobato, R. Ramos, JP. Arrebola, I. Calvente, O. Ocón-Hernández, C. Dávila-Arias, M. Pérez-García, N. Olea, MF. Fernández. Thyroid status and its association with cognitive functioning in healthy boys at 10 years of age.. European journal of endocrinology. 2015 172(2): pp. 129 - 139. FI: 3.892 (Cuartil Q1). (doi:10.1530/EJE-14-0093 PMID:25394567)
  • J. Martinez-Galan, C. Gonzalez-Rivas, JR. Vozmediano, L. Castillo, L. Ochoa, JR. Delgado. 170PMODIFICATION OF METHYLATION LEVEL DNA PROMOTER IN SERUM OF A PANEL OF GENE BEFORE AND AFTER TREATMENT AND IMPACT IN PROGNOSTIC FACTOR IN PATIENTS WITH BREAST CANCER.. Annals of oncology : official journal of the European Society for Medical Oncology. 2014 25(suppl_4): pp. iv59 - iv59 (doi:10.1093/annonc/mdu326.4 PMID:28174870)
  • A. Abad, BM. Sureda, C. Grávalos, P. Escudero, C. Guillen-Ponce, A. Gómez, MJ. Safont, JG. Plazas, J. Sastre, C. Pericay, R. Dueñas, C. López, F. Losa, M. Valladares-Ayerbes, EG. Flores, LR. Díaz, L. Layos, A. Carrato, E. Aranda. 551PRAS ANALYSIS OF THE PLANET STUDY: PHASE II TRIAL OF PANITUMUMAB (P) PLUS FOLFOX4 OR FOLFIRI IN SUBJECTS WITH WILD-TYPE (WT) KRAS COLORECTAL CANCER (CRC) AND LIVER-LIMITED DISEASE (LLD).. Annals of oncology : official journal of the European Society for Medical Oncology. 2014 25(suppl_4): pp. iv189 - iv189 (doi:10.1093/annonc/mdu333.53 PMID:28174863)
  • I. Blancas, M. Fontanillas, V. Conde Herrero, J. Lao, E. Martinez de Dueñas, M. Sotelo Lezama, A. JaÉn-Morago, JL. Bayo, F. Carabantes, JJ. Illaramendi, M. Gordón, M. Ruiz-Borrego, J. Cruz, A. García-Palomo, C. Mendiola, E. Perez-Ruiz, JM. Cañada, N. Martínez, G. Esquerdo, JS. Bofill. 362PASSESSMENT OF TREATMENT RESPONSE WITH FULVESTRANT (F) 500 MG IN STANDARD CLINICAL PRACTICE THROUGH A RETROSPECTIVE STUDY: NCT01509625.. Annals of oncology : official journal of the European Society for Medical Oncology. 2014 25(suppl_4): pp. iv120 - iv120 (doi:10.1093/annonc/mdu329.12 PMID:28172120)
  • C. Balana, C. Sanz, JL. Ramirez, JM. Gil, JM. Sepúlveda, R. De Las Penas, R. Luque, O. Gallego, G. Reynes, C. Carrato, B. Sanchez, A. Herrero, A. Berrocal, P. Perez Segura, A. Garcia Castano, S. Peralta, S. Vazquez, I. Fernández Perez, M. Martinez-Garcia. 417OMGMT METHYLATION IN TISSUE AND SERUM FROM UNRESECTABLE GLIOBLASTOMA (GBM) PATIENTS (P) INCLUDED IN THE GENOM 009 STUDY, A MULTICENTER RANDOMIZED STUDY BY THE GEINO GROUP COMPARING TEMOZOLOMIDE (TMZ) VERSUS TMZ-PLUS-BEVACIZUMAB (BEV). (CLINICALTRIALS.G. Annals of oncology : official journal of the European Society for Medical Oncology. 2014 25(suppl_4): pp. iv138 - iv138 (doi:10.1093/annonc/mdu330.4 PMID:28171969)
  • R. Hitt, R. Mesia, JJ. Grau, J. Rubió, J. Martínez-Trufero, E. Del Barco Morillo, C. Almodóvar Alvarez, M. Taberna-Sanz, C. García-Girón, S. Vazquez, B. Cirauqui, M. Pastor Borgoñón, E. Galve Calvo, O. Juan-Vidal, R. Lopez, J. Martinez-Galan, R. Bastus, A. Berrocal, JC. Adansa Klain, JJ. Cruz Hernandez. 1035PINDUCTION CHEMOTHERAPY (ICT) WITH DOCETAXEL/CISPLATIN/5-FLUOROURACIL (T/P/F) FOLLOWED BY CHEMORADIOTHERAPY WITH CISPLATIN (CRTP) VS BIORADIOTHERAPY WITH CETUXIMAB (RTCX) FOR UNRESECTABLE LOCALLY ADVANCED HEAD & NECK CANCER (ULAHNC): PRELIMINARY RESUL. Annals of oncology : official journal of the European Society for Medical Oncology. 2014 25(suppl_4): pp. iv355 - iv356 (doi:10.1093/annonc/mdu340.50 PMID:28171508)
  • PG. Alfonso, M. Benavides, AS. Ruiz, C. Guillen-Ponce, MJ. Safont, J. Alcaide, A. Gómez, R. Lopez, JL. Manzano, MM. Urena, F. Rivera, J. Sastre, C. Grávalos, TG. García, JI. Martin-Valades, E. Falco, EG. Flores, M. Navalón, ED. Rubio, E. Aranda. 499OPHASE II STUDY OF FIRST-LINE MFOLFOX PLUS CETUXIMAB (C) FOR 8 CYCLES FOLLOWED BY MFOLFOX PLUS C OR SINGLE AGENT (S/A) C AS MAINTENANCE THERAPY IN PATIENTS (P) WITH METASTATIC COLORECTAL CANCER (MCRC): THE MACRO-2 TRIAL (SPANISH COOPERATIVE GROUP FOR T. Annals of oncology : official journal of the European Society for Medical Oncology. 2014 25(suppl_4): pp. iv168 - iv168 (doi:10.1093/annonc/mdu333.3 PMID:28171367)
  • I. Duran, C. Hagen, JA. Arija, M. Apellaniz, B. Pérez-Valderrama, N. Sala Gonzalez, N. Lainez, X. Garcia Del Muro, E. Nogueron, M. Climent, P. Maroto, A. Font, J. Garcia-Donas, E. Gallardo, P. Lopez Criado, A. Gonzalez Del Alba, MI. Saez, S. Vazquez, R. Luque, C. Rodriguez-Antona. 869PPHARMACOGENETIC STUDY OF CABAZITAXEL IN ADVANCED OR METASTATIC TRANSITIONAL CELL CARCINOMA (TCC): THE SOGUG 2011-04 TRIAL.. Annals of oncology : official journal of the European Society for Medical Oncology. 2014 25(suppl_4): pp. iv302 - iv303 (doi:10.1093/annonc/mdu337.62 PMID:28171229)
  • P. Maroto, N. Lainez, E. Esteban, M. Espinosa, MJ. Juan, O. Etxaniz, C. Suarez, JM. Sepúlveda, G. Rubio, JA. Arija, L. Jimenez, MI. Saez, J. Puente, IC. Gonzalez, E. Gallardo, JM. Jurado, J. Garcia-Donas, ML. Brea, M. Garrido, DS. Otero. 849PREAL LIFE EFFICACY AND SAFETY OF AXITINIB (AXI) IN PATIENTS WITH RENAL CELL CARCINOMA (RCC): RESULTS FROM THE SPANISH COMPASSIONATE USE PROGRAM.. Annals of oncology : official journal of the European Society for Medical Oncology. 2014 25(suppl_4): pp. iv296 - iv296 (doi:10.1093/annonc/mdu337.42 PMID:28170958)
  • MS. Lezama, J. Sastre, S. Veganzones, V. Orden, JM. Viéitez, V. Alonso, C. Grávalos, P. Escudero, R. Vera, E. Aranda, PG. Alfonso, JG. Plazas, C. López, C. Pericay, A. Arrivi, MP. Lazcano, P. Ballesteros, E. Elez, A. López-Ladrón, E. Díaz-Rubio. 567PROLE OF CIRCULATING TUMOR CELLS (CTC) IN STAGE III COLORECTAL CANCER (CRC).. Annals of oncology : official journal of the European Society for Medical Oncology. 2014 25(suppl_4): pp. iv194 - iv194 (doi:10.1093/annonc/mdu333.69 PMID:28170842)
  • I. Blancas, N. Cárdenas, M. Delgado, JM. Jurado, M. Legeren, A. Villaescusa, F. Galvez, M. Yelamos. Late relapse of non-seminomatous testicular cancer during treatment of multiple sclerosis with interferon β-1a: A case report.. Oncology letters. 2014 8(5): pp. 2179 - 2182 (doi:10.3892/ol.2014.2519 PMID:25289098)
  • MJ. Serrano, FG. Ortega, MJ. Alvarez-Cubero, R. Nadal, P. Sanchez-Rovira, M. Salido, M. Rodríguez, JL. García-Puche, M. Delgado-Rodriguez, F. Solé, MA. García, M. Perán, R. Rosell, JA. Marchal, JA. Lorente. EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer.. Oncotarget. 2014 5(17): pp. 7486 - 7497. FI: 6.627 (Cuartil 1 - Decil 2). (doi:10.18632/oncotarget.2217 PMID:25277187)
  • I. Tovar, J. Expósito, J. Jaén, E. Alonso, M. Martínez, R. Guerrero, JP. Arrebola, R. Del Moral. Pattern of use of radiotherapy for lung cancer: a descriptive study.. BMC cancer. 2014 14(1): pp. 697 - 697. FI: 3.319 (Cuartil 2 - Decil 8). (doi:10.1186/1471-2407-14-697 PMID:25245473)
  • JP. Arrebola, MF. Fernández, P. Martín-Olmedo, JM. Molina-Molina, MJ. Sánchez-Pérez, E. Sánchez-Cantalejo, E. Molina-Portillo, J. Expósito, JP. Bonde, N. Olea. Adipose tissue concentrations of persistent organic pollutants and total cancer risk in an adult cohort from Southern Spain: Preliminary data from year 9 of the follow-up.. The Science of the total environment. 2014 500-501C: pp. 243 - 249. FI: 3.163 (Cuartil 1 - Decil 4). (doi:10.1016/j.scitotenv.2014.08.043 PMID:25217999)
  • JP. Arrebola, R. Ocaña-Riola, AL. Arrebola-Moreno, M. Fernández-Rodríguez, P. Martin-Olmedo, MF. Fernández, N. Olea. Associations of accumulated exposure to persistent organic pollutants with serum lipids and obesity in an adult cohort from Southern Spain.. Environmental pollution (Barking, Essex : 1987). 2014 195C: pp. 9 - 15. FI: 3.902 (Cuartil 1 - Decil 3). (doi:10.1016/j.envpol.2014.08.003 PMID:25173983)
  • A. Berrocal, A. Arance, JA. Lopez Martin, V. Soriano, E. Muñoz, L. Alonso, E. Espinosa, P. Lopez Criado, J. Valdivia, S. Martin Algarra. Ipilimumab for advanced melanoma: experience from the Spanish Expanded Access Program.. Melanoma research. 2014 24(6): pp. 577 - 583. FI: 2.098 (Cuartil 2 - Decil 2). (doi:10.1097/CMR.0000000000000108 PMID:25046550)
  • C. Torres, S. Perales, MJ. Alejandre, J. Iglesias, RJ. Palomino, M. Martin, O. Caba, JC. Prados, A. Aránega, JR. Delgado, A. Irigoyen, FM. Ortuño, I. Rojas, A. Linares. Serum Cytokine Profile in Patients With Pancreatic Cancer.. Pancreas. 2014 43(7): pp. 1042 - 1049. FI: 2.953. (doi:10.1097/MPA.0000000000000155 PMID:24979617)
  • E. López-Ruiz, M. Perán, M. Picón-Ruiz, MA. García, E. Carrillo, M. Jiménez-Navarro, MC. Hernández, I. Prat, E. De Teresa, JA. Marchal. Cardiomyogenic differentiation potential of human endothelial progenitor cells isolated from patients with myocardial infarction.. Cytotherapy. 2014 16(9): pp. 1229 - 1237. FI: 3.055 (Cuartil 2 - Decil 5). (doi:10.1016/j.jcyt.2014.05.012 PMID:24969968)
  • A. Ramírez, H. Boulaiz, C. Morata-Tarifa, M. Perán, G. Jiménez, M. Picon-Ruiz, A. Agil, O. Cruz-López, A. Conejo-García, JM. Campos, A. Sánchez, MA. García, JA. Marchal. HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib small compound.. Oncotarget. 2014 5(11): pp. 3590 - 3606. FI: 6.627 (Cuartil 1 - Decil 3). (doi:10.18632/oncotarget.1962 PMID:24946763)
  • M. Martínez-Carrillo, I. Tovar-Martín, M. Zurita-Herrera, R. Del Moral-Ávila, R. Guerrero-Tejada, E. Saura-Rojas, JL. Osorio-Ceballos, JP. Arrebola-Moreno, J. Expósito-Hernández. Salvage radiosurgery for selected patients with recurrent malignant gliomas. BioMed research international. 2014 2014: pp. 657953 - 657953. FI: 2.88 (Cuartil 2 - Decil 5). (doi:10.1155/2014/657953 PMID:24895599)
  • J. Martinez-Galan, C. González-Rivas, JR. Delgado. 45p * methylation of DNA free in blood sample as prognostic factor in breast cancer subtype.. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2014 25 Suppl 1: pp. i15 - i15. FI: 7.384 (Cuartil 1 - Decil 2). (doi:10.1093/annonc/mdu066.26 PMID:24764381)
  • E. Martinez de Dueñas, E. Ochoa Aranda, I. Blancas Lopez-Barajas, T. Ferrer Magdalena, F. Bandrés Moya, LM. Chicharro García, JA. Gómez Capilla, M. Zafra Ceres, T. de Haro, R. Romero Llorens, C. Ferrer Albiach, R. Ferriols Lisart, D. Chover Lara, A. López Rodríguez, J. Munárriz Ferrandis, S. Olmos Antón. Adjusting the dose of tamoxifen in patients with early breast cancer and CYP2D6 poor metabolizer phenotype.. Breast (Edinburgh, Scotland). 2014 23(4): pp. 400 - 406 (doi:10.1016/j.breast.2014.02.008 PMID:24685597)
  • JA. Marchal, GJ. Lopez, M. Peran, A. Comino, JR. Delgado, JA. García-García, V. Conde, FM. Aranda, C. Rivas, M. Esteban, MA. Garcia. The impact of PKR activation: From neurodegeneration to cancer. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 2014 28(5): pp. 1965 - 1974. FI: 5.704 (Cuartil 1 - Decil 1). (doi:10.1096/fj.13-248294 PMID:24522206)
  • J. Martínez-Galán, B. Torres-Torres, MI. Núñez, J. López-Peñalver, R. Del Moral, JM. Ruiz De Almodóvar, S. Menjón, A. Concha, C. Chamorro, S. Ríos, JR. Delgado. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients. BMC cancer. 2014 14(1): pp. 59 - 59. FI: 3.319. (doi:10.1186/1471-2407-14-59 PMID:24495356)
  • S. Faivre, D. Castellano, J. Strosberg, E. González, R. Salazar. Pancreatic NETs: Where do we stand now?. Cancer Metastasis Rev.. 2014 33(1): pp. 361 - 366. FI: 7.787 (Cuartil 1 - Decil 2). (doi:10.1007/s10555-013-9466-0 )
  • . Castellón, . , E. Gonzalez. Envejecimiento y cáncer. Oncogeriatria. 2014
  • A. Rueda, J. Rifá, C. Quero, J. Gómez Codina, A. Murias, FR. García Arroyo, P. Sabín, M. Llanos, J. Herrero, F. Lobo, JR. Delgado, M. Provencio. High serum levels of vascular endothelial growth factor-C have a positive impact on outcome of patients with advanced diffuse large B cell lymphoma. Leuk. Lymphoma. 2014 55(6): pp. 1413 - 1416. FI: 2.301 (Cuartil 3 - Decil 4). (doi:10.3109/10428194.2013.836601 )
  • . Castellón, E. Gonzalez, . . Envejecimiento y cáncer. Oncogeriatria. 2014
  • . . Relevancia´Clínica de los receptores hormonales en la decisión terapéutica del cáncer de mama. El informe de anatomía patlógica y su relevancia en el tratamiento del cáncer de mama. 2014
  • . . Metástasis de tumores neuroendocrinos en localizaciones raras. Biblionet. 2014 7(1): pp. 1
  • . . Tumores digestivos distintos del cáncer colorrectal. Oncogeriatria. 2014
  • R. García Carbonero, F. Vilardell, P. Jiménez Fonseca, R. González Campora, E. González, M. Cuatrecasas, J. Capdevila, I. Aranda, J. Barriuso, X. Matías Guiu. Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: A national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology. Clin. Transl. Oncol.. 2014 16(3): pp. 243 - 256. FI: 1.276 (Cuartil 4 - Decil 4). (doi:10.1007/s12094-013-1062-9 )
  • . . Cáncer colorrectal en el mayor. Oncogeriatria. 2014
  • M. Provencio, MA. Cruz Mora, J. Gómez Codina, C. Quero Blanco, M. Llanos, FR. García Arroyo, L. De La Cruz, J. Gumá Padró, JR. Delgado Pérez, A. Sánchez, R. Álvarez Cabellos, A. Rueda. Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: A multicenter, prospective phase. Leuk. Lymphoma. 2014 55(1): pp. 51 - 55. FI: 2.301. (doi:10.3109/10428194.2013.790544 )
  • . . Como gestionar un comité multidisciplinario de cáncer colorrectal. Oncology plus ON LINE. 2014
Última actualización de datos: 16-08-2017
23.937.385 visitas desde el 1 de Marzo de 2006
Última actualización de la pagina: 15-06-2015 Subir
Certificación Emas Certificacion Responsabilidad Social Certificacion Gestión Ambiental Certificacion Seguridad Alimentaria Certificacion Salud Laboral
Las páginas del dominio hvn.es cumplen con las normas de accesibilidad WCAG 2.0 nivel AAA
hvn.es cumple con las normas de W3C para el lenguaje de marcado XHTML 1.0
hvn.es cumple con las normas de W3C para hojas de estilo
FIBAO IBS Logo de Green Light Logo de OMARS Logo de Living Lab Salud Andalucía Red de Comités de Ética del SSPA CEI Biotic - Granada
Datos de Contacto | Webmaster | Mapa web | Nota legal | Política editorial | Uso del sitio | Accesibilidad | Preguntas frecuentas | RSS
© 2003 - 2017. Hospital Universitario Virgen de las Nieves.
- HUVN -